RE:RE:RE:2018/2019 ExpectationsI much prefer using a P/S over EPS with Canopy in this current time period. If Canopy was profitable now, I probably wouldnt be invested. Yes, thjats right, I PROBABLY WOULDNT BE INVESTED. I'm not looking to invest in a profitable company in this current time with such a high multiple of growth on the horizon. I want to invest in a company whos looking to the future and capitilizing on a global industry. In order to do so, it involves spending $, AND LOTS OF IT!. As you can see, the market is fully supportive of that vision as am I. Profitability will come. We may not see the true potential of just how profitable this company will be until years down the road. Building brands and relationships is the most important right now. Anybody who does want to value a company on EPS, well go invest in a mature company like a bank. I'll be happy with my ROI over a bank all day long! LOL
55orbust wrote: saveyourselfnow wrote: Peyton wrote: Sorry, had to change the thread. I didnt want to reply to that thread and keep it going.
$75 is ridiculous by October. But it certainly isnt for sometime in 2019. 2019 revenues should be somewhere either just below, or just above $1 Billion. Our next big wave of growth will come when this thing starts snowballing globally. It has already begun, but its going to start coming on alot quicker in the next couple years. What I'm most excited for is the clinical trials that are currently ongoing. Once completed, we should have approval for a formulation and a DIN # shortly after. This is when things get the most exciting for me. Ive been invested since 2015/2016, and the one thing that excites me the most is the DIN #'s upcoming for Medical. That will be the final stamp for the upcoming global wave we are about to witness. There is really only 1 company in the world that has situated itself to capture this entire market to its fullest.
that would imply and EPS of $4.65 a share.and current EPS is negartive 15 cents a share so you are projecting an increase that isn't even capable of calculation without retuning ERROR on a calculator.
You are predicting and EPS that is 59% of the EPS of Canada's Biggest Bank - Royal Bank at an EPS of $7.83
DO YOU REALLY THINK ANY ANY ANY WEED STOCK COMES EVEN CLOSE TO THE STABILITY OF A BANK STOCK?
Royal Bank is one of the BIGGEST PLAYERS IN THE BANKING WORLD
and still you are willing to make claims that WEED will be within 41% of Royal Bank earnings in a couple of years? sheeeeeeeeeesh DO SOME DD!
In order for Royal Bank to post an earnings per share of $7.83 per share they have to generate profit of 11.35 billion. In order for canopy to generate $7.83 per share they have to generate a profit of 1.6 billion. Since I don't view you as being very intelligent I wouldn't think that you could figure that out. Keep in mind that banks have a very low PE multiple because they are a slow-growth establish business. Marijuana companies are speculative growth companies and command a much higher PE multiple. Get a grip.